Pittenger & Anderson Inc Gilead Sciences, Inc. Transaction History

Pittenger & Anderson Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $34,204 - $39,015	450 New	450 $34,000
Q2 2022 Jul 14, 2022	SELL	$57.72 - $65.01 $1,500 - $1,690	-26 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $1,505 - $1,887	26 New	26 $2,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $70,658 - $79,156	-1,130 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$71.28 - $78.92 $57,024 - $63,136	800 Added 242.42%	1,130 $87,000
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $11,029 - $12,865	-170 Reduced 34.0%	330 $23,000
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $5,098 - $6,216	70 Added 16.28%	500 $38,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $14,230 - $16,704	200 Added 86.96%	430 $31,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $7,571 - $8,974	105 Added 84.0%	230 $19,000
Q2 2017 Aug 10, 2017	BUY	N/A	125	125 $9,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.